HealthEquity, Inc. $HQY is 12th Street Asset Management Company LLC’s 10th Largest Position

12th Street Asset Management Company LLC lifted its holdings in HealthEquity, Inc. (NASDAQ:HQY) by 114.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 272,068 shares of the company’s stock after acquiring an additional 145,151 shares during the period. HealthEquity makes up 4.4% of 12th Street Asset Management Company LLC’s portfolio, making the stock its 10th biggest position. 12th Street Asset Management Company LLC’s holdings in HealthEquity were worth $25,784,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in HQY. Atria Investments Inc grew its holdings in shares of HealthEquity by 68.5% in the 3rd quarter. Atria Investments Inc now owns 37,742 shares of the company’s stock worth $3,577,000 after acquiring an additional 15,347 shares during the last quarter. Illinois Municipal Retirement Fund acquired a new position in shares of HealthEquity during the 3rd quarter worth $763,000. Oppenheimer Asset Management Inc. increased its position in HealthEquity by 45.5% during the third quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock worth $14,741,000 after buying an additional 48,621 shares during the last quarter. Alps Advisors Inc. increased its holdings in shares of HealthEquity by 15.9% during the 3rd quarter. Alps Advisors Inc. now owns 9,403 shares of the company’s stock valued at $891,000 after acquiring an additional 1,288 shares during the last quarter. Finally, Renaissance Group LLC lifted its position in HealthEquity by 8.8% during the 3rd quarter. Renaissance Group LLC now owns 80,494 shares of the company’s stock worth $7,628,000 after acquiring an additional 6,539 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the sale, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 13,959 shares of company stock valued at $1,344,957 in the last quarter. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Stock Performance

HQY opened at $73.21 on Friday. The business’s 50-day simple moving average is $88.81 and its 200 day simple moving average is $92.45. HealthEquity, Inc. has a 52-week low of $72.99 and a 52-week high of $116.65. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. The firm has a market capitalization of $6.26 billion, a PE ratio of 33.58, a PEG ratio of 0.96 and a beta of 0.24.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.11. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, sell-side analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HQY. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $120.00 price target on shares of HealthEquity in a research note on Friday, December 5th. Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Citizens Jmp raised their price target on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a report on Thursday, December 4th. KeyCorp raised their price target on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, January 8th. Finally, Barclays assumed coverage on shares of HealthEquity in a report on Monday, December 8th. They set an “overweight” rating and a $118.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $119.60.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.